Treatment of Pulmonary Embolism During Pregnancy and the Post-Partum Period

Clinical Scenario

Acute pulmonary embolism (PE) occurring during pregnancy or within 6 weeks of delivery constitutes a distinct clinical scenario. The physiological context of pregnancy requires a carefully tailored management approach that differs from standard PE treatment.

Pregnancy-Specific Considerations

For the majority of pregnant patients without haemodynamic instability, anticoagulant therapy is the treatment of choice. LMWH is the preferred anticoagulant in this setting, with dosing guided by early pregnancy body weight — full dosing and monitoring details are in the complete protocol.

High-Risk Presentations

For patients with haemodynamic instability, the protocol defines specific escalation strategies beyond anticoagulation — the complete risk-stratified decision pathway is available in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/eurheartj/ehz405

LMWH is the treatment of choice for PE during pregnancy.
A therapeutic, fixed dose of LMWH based on early pregnancy body weight is the recommended therapy for PE in the majority of pregnant women without haemodynamic instability.
Thrombolysis or surgical embolectomy should be considered for pregnant women with high-risk PE.
Typically, UFH is used in the acute treatment of high-risk PE.

View source ↗